2.5K Views
•
09:40 min
•
August 2nd, 2024
DOI :
August 2nd, 2024
•Explore More Videos
Chapters in this video
0:00
Introduction
0:51
Analyzing the Expression of TMOD3 in Normal Ovarian Tissues and Ovarian Cancer
2:23
Assessing the Effect of TMOD3 on Overall Survival and Progression‐Free Survival (PFS) in Ovarian Cancer Patients
4:15
TMOD3 Expression Analysis in Platinum‐Based Chemotherapy Resistant and Sensitive Patients and mRNA‐miRNA Analysis
6:56
Checking the Distribution of TMOD3 in Immune Cells and TMOD3 Coexpression Networks in Ovarian Cancer
Related Videos
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
8.7K Views
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
9.5K Views
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
8.8K Views
Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
8.5K Views
A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
8.7K Views
Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis
5.7K Views
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
6.6K Views
Characterization and Functional Prediction of Bacteria in Ovarian Tissues
2.7K Views
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
4.7K Views
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
3.1K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved